Michael J Mastrangelo

Title: Michael J Mastrangelo: Innovator in Cancer Treatment

Introduction

Michael J Mastrangelo is a prominent inventor based in Jenkintown, PA (US). He has made significant contributions to the field of immunology and cancer treatment, holding a total of 3 patents. His work focuses on utilizing vaccinia virus vectors to enhance immune responses and treat various forms of cancer.

Latest Patents

Mastrangelo's latest patents include a method of inducing an immune response using vaccinia virus recombinants. This innovative method involves generating a vaccinia virus vector capable of inducing expression of selected immune-active cytokines in tumors. The vector is injected into the tumor, allowing the tumor cells to express the selected cytokine. Additionally, he has developed methods for enhancing immunity in a host through the administration of these vaccinia virus vectors. Another notable patent addresses the treatment of bladder cancer using wild type vaccinia virus, providing new avenues for patient care.

Career Highlights

Michael J Mastrangelo is affiliated with Thomas Jefferson University, where he continues to advance research in cancer treatment and immunology. His work has garnered attention for its potential to improve therapeutic outcomes for patients suffering from cancer.

Collaborations

Mastrangelo collaborates with esteemed colleagues such as Edmund C Lattime and David Berd, contributing to a dynamic research environment focused on innovative cancer therapies.

Conclusion

Michael J Mastrangelo's contributions to the field of cancer treatment through his patents and research at Thomas Jefferson University highlight his commitment to advancing medical science. His innovative approaches have the potential to significantly impact patient care and treatment outcomes.